QVirus™ Platform can produce high yields of lentiviruses encoding the components necessary for CRISPR/Cas9-mediated genome editing (i.e., sgRNA and Cas9 nuclease) for delivery to mammalian cells that are difficult to transfect. If you have any special requirements, please feel free to contact us. crispr-cas9 lentivirus https://qvirus.creative-biogene.com/solution/crispr-cas9-lentivirus-production-service.html
